PubMed

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.

Worm SW, Friis-Møller N, Bruyand M, Monforte AD, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C; for the D:A:D study group.

AIDS. 2009 Nov 11. [Epub ahead of print]PMID: 19910787 [PubMed - as supplied by publisher]Related articles

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

Kowalska J, Kirk O, Mocroft A, Høj L, Friis-Møller N, Reiss P, Weller I, Lundgren J.

HIV Med. 2009 Oct 27. [Epub ahead of print]PMID: 19863618 [PubMed - as supplied by publisher]Related articles

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

Duprez DA, Kuller LH, Tracy R, Otvos J, Cooper DA, Hoy J, Neuhaus J, Paton NI, Friis-Moller N, Lampe F, Liappis AP, Neaton JD; for the INSIGHT SMART Study Group.

Atherosclerosis. 2009 May 13. [Epub ahead of print]PMID: 19515371 [PubMed - as supplied by publisher]Related articles

[Carbon monoxide poisoning]

Sinding M, Friis-Møller N.

Ugeskr Laeger. 2009 Apr 6;171(15):1298. Danish. PMID: 19416624 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral therapy as a cardiovascular disease risk factor: fact or fiction? A review of clinical and surrogate outcome studies.

Friis-Møller N, Smieja M, Klein D.

Curr Opin HIV AIDS. 2008 May;3(3):220-225.PMID: 19372970 [PubMed - as supplied by publisher]Related articles

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

Circulation. 2009 Feb 17;119(6):805-11. Epub 2009 Feb 2.PMID: 19188509 [PubMed - indexed for MEDLINE]Related articlesFree article

Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.

Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte A, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N.

Diabetes Care. 2009 Mar;32(3):474-80. Epub 2008 Dec 3.PMID: 19056612 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

AIDS. 2008 Oct 18;22(16):2143-53.PMID: 18832878 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence of abacavir hypersensitivity reactions in euroSIDA.

Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD; EuroSIDA Study Group.

Antivir Ther. 2008;13(5):687-96.PMID: 18771052 [PubMed - indexed for MEDLINE]Related articles

Prevention strategies for cardiovascular disease in HIV-infected patients.

Stein JH, Hadigan CM, Brown TT, Chadwick E, Feinberg J, Friis-Møller N, Ganesan A, Glesby MJ, Hardy D, Kaplan RC, Kim P, Lo J, Martinez E, Sosman JM; Working Group 6.

Circulation. 2008 Jul 8;118(2):e54-60. Epub 2008 Jun 19. No abstract available. PMID: 18566315 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10.PMID: 18461712 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292. PMID: 18387667 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Diabetes Care. 2008 Jun;31(6):1224-9. Epub 2008 Feb 11.PMID: 18268071 [PubMed - indexed for MEDLINE]Related articlesFree article

Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?

Friis-Møller N, Worm SW.

Clin Infect Dis. 2007 Oct 15;45(8):1082-4. Epub 2007 Sep 12. No abstract available. PMID: 17879929 [PubMed - indexed for MEDLINE]Related articles

Class of antiretroviral drugs and the risk of myocardial infarction.

DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.

N Engl J Med. 2007 Apr 26;356(17):1723-35.PMID: 17460226 [PubMed - indexed for MEDLINE]Related articlesFree article

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD.

Arch Intern Med. 2006 Aug 14-28;166(15):1632-41.PMID: 16908797 [PubMed - indexed for MEDLINE]Related articlesFree article

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

Law MG, Friis-Møller N, El-Sadr WM, Weber R, Reiss P, D'Arminio Monforte A, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Kirk O, Sabin CA, Phillips AN, Lundgren JD; D:A:D Study Group.

HIV Med. 2006 May;7(4):218-30.PMID: 16630034 [PubMed - indexed for MEDLINE]Related articles

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD; Data Collection of Adverse events of anti-HIV Drugs Study Group.

Antivir Ther. 2005;10(7):811-23. Erratum in: Antivir Ther. 2005;10(8):969. PMID: 16315369 [PubMed - indexed for MEDLINE]Related articles

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.

Olsen CH, Gatell J, Ledergerber B, Katlama C, Friis-Møller N, Weber J, Horban A, Staszewski S, Lundgren JD, Phillips AN; EuroSIDA Study Group.

AIDS. 2005 Feb 18;19(3):319-30.PMID: 15718843 [PubMed - indexed for MEDLINE]Related articles

Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.

Mocroft A, Monforte A, Kirk O, Johnson MA, Friis-Moller N, Banhegyi D, Blaxhult A, Mulcahy F, Gatell JM, Lundgren JD; EuroSIDA study group.

HIV Med. 2004 Nov;5(6):437-47.PMID: 15544697 [PubMed - indexed for MEDLINE]Related articles

Cardio- and cerebrovascular events in HIV-infected persons.

d'Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Lundgren JD, Friis-Møller N; Writing Committee of the D:A:D: Study Group.

AIDS. 2004 Sep 3;18(13):1811-7.PMID: 15316342 [PubMed - indexed for MEDLINE]Related articles

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

Fontas E, van Leth F, Sabin CA, Friis-Møller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, Reiss P; D:A:D Study Group.

J Infect Dis. 2004 Mar 15;189(6):1056-74. Epub 2004 Mar 2.PMID: 14999610 [PubMed - indexed for MEDLINE]Related articles

Combination antiretroviral therapy and the risk of myocardial infarction.

Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group.

N Engl J Med. 2003 Nov 20;349(21):1993-2003. Erratum in: N Engl J Med. 2004 Feb 26;350(9):955. PMID: 14627784 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function.

Andersen O, Haugaard SB, Andersen UB, Friis-Møller N, Storgaard H, Vølund A, Nielsen JO, Iversen J, Madsbad S.

Metabolism. 2003 Oct;52(10):1343-53.PMID: 14564688 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group.

AIDS. 2003 May 23;17(8):1179-93.PMID: 12819520 [PubMed - indexed for MEDLINE]Related articles

Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

Law M, Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Calvo G, El-Sadr W, De Wit S, Sabin CA, Lundgren JD; DAD Study Group.

HIV Med. 2003 Jan;4(1):1-10.PMID: 12534953 [PubMed - indexed for MEDLINE]Related articles

Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study.

Mocroft A, Phillips AN, Friis-Møller N, Colebunders R, Johnson AM, Hirschel B, Saint-Marc T, Staub T, Clotet B, Lundgren JD; EuroSIDA study group.

Antivir Ther. 2002 Mar;7(1):21-30.PMID: 12008784 [PubMed - indexed for MEDLINE]Related articles

Highly active antiretroviral therapy and coronary heart disease: the need for perspective.

Egger M, Junghans C, Friis-Møller N, Lundgren JD.

AIDS. 2001;15 Suppl 5:S193-201. Review. No abstract available. PMID: 11816168 [PubMed - indexed for MEDLINE]Related articles